Half a year after being spurned by the FDA and following deep layoffs, IO Biotech has decided to close its doors for good.

Mantis takes disparate sources of data to make synthetic datasets that can be used to build so-called "digital twins" of the ...

While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...

U.S. venture capital firms are no longer waiting for Chinese biotech assets to surface before investing in them — they’re ...

Shares of IO Biotech, Inc. IOBT are plummeting Tuesday after the company announced it filed for Chapter 7 bankruptcy and will ...

Mantis Biotechnology Corp, a San Francisco-based startup, is building simulated human bodies to generate the synthetic ...

The six companies that have priced initial public offerings so far banked a median of $287.5 million, a figure far surpassing ...

Discover the Latest in Research Peptides at Biotech Labz Supply Sebastopol, United States - January 3, 2026 / Biotech ...

CNBC's Angelica Peebles reports the latest news surrounding Big Pharma.

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going ...

This little-known biotech could have a big hit on its hands with VK2735, a GLP-1 weight loss drug candidate.

PSC Biotech partners with Blue Ocean Robotics to distribute the UVD Robot Pharma delivering autonomous UV C disinfection for GMP cleanroom environments. Purpose built for GMP cleanroom environments, ...